𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Pharmacokinetics and relative bioavailability of oral theophylline capsules

✍ Scribed by L. J. Lesko; A. T. Canada; G. Eastwood; D. Walker; D. R. Brousseau


Publisher
John Wiley and Sons
Year
1979
Tongue
English
Weight
435 KB
Volume
68
Category
Article
ISSN
0022-3549

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Pharmacokinetics and oral bioavailabilit
✍ R. Obach; J. Torrent; H. Colom; J. PruΓ±onosa; C. Peraire; J. Domenech πŸ“‚ Article πŸ“… 1991 πŸ› John Wiley and Sons 🌐 English βš– 501 KB

## Abstract A pharmacokinetic study of carbimide, an inhibitor of aldehyde dehydrogenase, used as an adjuvant in the aversive therapy of chronic alcoholism, has been carried out in male human volunteers for intravenous and oral administration. Carbimide plasma concentrations were determined by a se

Steady state relative bioavailability an
✍ Melvin Sharoky; Mark Perkal; Robert Turner; L. J. Lesko πŸ“‚ Article πŸ“… 1988 πŸ› John Wiley and Sons 🌐 English βš– 583 KB

The steady state bioavailability and pharmacokinetics of propranolol over two consecutive dosing intervals were investigated in 18 black and 10 white normal volunteers following the administration of 20 mg of a test and reference oral dosage form, respectively, every 6h. There were no differences (p

Pharmacokinetics and relative bioavailab
✍ Iftekhar Mahmood; Jacqueline S. Marinac; Sandra Willsie; William D. Mason πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 English βš– 557 KB

## Abstract Selegiline is beneficial to Parkinsonian patients as an adjunct to levodopa therapy. A sensitive fluorimetric assay based on ibhibition of rat brain monoamine oxidase‐B (MAO‐B) __in vitro__ has been developed to study the pharmacokinetics of selegiline. This method quantitates selegilin

Pharmacokinetics and bioavailability of
✍ A. N. J. A. De Groot; T. B. Vree; Y. A. Hekster; M. Van Den Biggelaar-Martea; P. πŸ“‚ Article πŸ“… 1994 πŸ› John Wiley and Sons 🌐 English βš– 380 KB πŸ‘ 2 views

The aim of this investigation was to assess the pharmacokinetics and bioavailability of ergometrine in six human male subjects after an oral dose of 0.200 mg and after an intravenous dose of 0.075 mg of ergometrine maleate. A large variation in bioavailability of between 34% and 117% in the six volu